Exo Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Exo Therapeutics's estimated annual revenue is currently $5.1M per year.
- Exo Therapeutics's estimated revenue per employee is $155,000
Employee Data
- Exo Therapeutics has 33 Employees.
Exo Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | VP, Discovery & Translational Biology | Reveal Email/Phone |
3 | SVP, Finance & Operations | Reveal Email/Phone |
4 | SVP, Platform & Discovery | Reveal Email/Phone |
5 | VP, Information Technology | Reveal Email/Phone |
6 | Director, Bioinformatics | Reveal Email/Phone |
7 | Director, Computational Chemistry | Reveal Email/Phone |
8 | Senior Director, Controller | Reveal Email/Phone |
9 | Senior Director, Human Resources | Reveal Email/Phone |
10 | Principal Scientist, Medicinal Chemistry | Reveal Email/Phone |
Exo Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5.2M | 67 | -45% | $107.3M | N/A |
#2 | $0.3M | 2 | 0% | N/A | N/A |
#3 | $5.1M | 33 | 6% | N/A | N/A |
#4 | $11.9M | 77 | -37% | $312.8M | N/A |
#5 | $0.9M | 6 | 0% | N/A | N/A |
#6 | $235M | 300 | -5% | $340.9M | N/A |
#7 | $45.9M | 237 | -7% | $7.6M | N/A |
#8 | $3.9M | 50 | 35% | N/A | N/A |
#9 | $5.4M | 35 | 3% | N/A | N/A |
#10 | $1.6M | 10 | 0% | N/A | N/A |
What Is Exo Therapeutics?
Exo Therapeutics is a small molecule drug discovery and development company with a pioneering technology to address intractable pharmaceutical targets. By leveraging the company's ExoSightTM platform, Exo is developing a deep pipeline of potent drug candidates that bind exosites, distal and unique binding pockets that have the potential to reprogram enzyme activity for precise and robust therapeutic effect. Through this specific and selective approach to challenging targets, the company's team of world-class researchers is unlocking breakthrough therapeutics in oncology, inflammation and a broad range of other diseases.
keywords:N/A
N/A
Total Funding
33
Number of Employees
$5.1M
Revenue (est)
N/A
Employee Growth %
N/A
Valuation
N/A
Accelerator
Exo Therapeutics News
Paul Schneider will be the new CFO of Freeline, jumping from Exo Therapeutics where he was SVP of finance and operations.
BioXcel Therapeutics aims to become the leading ... jumping from Exo Therapeutics where he was SVP of finance and operations.
The tests not only proved the therapies' application against disease ... from Exo Therapeutics where he was SVP of finance and operations.
Other Companies in Cambridge
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $6.7M | 33 | 10% | N/A |
#2 | $3.8M | 33 | 6% | N/A |
#3 | $4.8M | 33 | 57% | N/A |
#4 | $3.7M | 33 | -8% | N/A |
#5 | N/A | 33 | 32% | N/A |